Companies / EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc.
EPRSCIK 1135906
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 4, 2015 | Rocklage Scott M +1 co-filer Director | Buy Open-market buy | Common Stock | $1.95M | +390K +18.06% | 2,549,211 | high |
| Feb 6, 2015 | Montreux Equity Partners IV LP 10% owner | Sell Open-market sale | Common Stock | $500.9K | -100K -5.65% | 1,671,400 | medium |
| Feb 5, 2015 | Montreux Equity Partners IV LP 10% owner | Sell Open-market sale | Common Stock | $334.8K | -67K -3.66% | 1,771,400 | medium |
| Jan 26, 2015 | Montreux Equity Partners IV LP 10% owner | Sell Open-market sale | Common Stock | $249.1K | -39K -2.00% | 1,891,400 | medium |
| Feb 3, 2015 | Montreux Equity Partners IV LP 10% owner | Sell Open-market sale | Common Stock | $234.4K | -47K -2.48% | 1,844,400 | medium |
| Jan 22, 2015 | Montreux Equity Partners IV LP 10% owner | Sell Open-market sale | Common Stock | $89.0K | -14K -0.72% | 1,938,316 | low |
| Jan 23, 2015 | Montreux Equity Partners IV LP 10% owner | Sell Open-market sale | Common Stock | $52.7K | -8K -0.43% | 1,929,916 | low |
| Feb 4, 2015 | Rocklage Scott M +1 co-filer Director | Buy Open-market buy | Common Stock | $50.3K | +10K +18.06% | 65,699 | low |